Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 30
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Bull Exp Biol Med ; 160(3): 350-2, 2016 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-26750927

RESUMO

The effects of recombinant analog of natural Ebola virus protein vp24 in configurations virulent (vp24-ad) and avirulent (vp24-w) for guinea pigs on interferonogenesis were studied in vivo and in vitro. Amino acid differences were determined by His186 substitution in avirulent (nonlethal) configuration for Tyr in the virulent (lethal) one. Recombinant analogs vp24-w and vp24-ad inhibited interferonogenesis in vivo and in vitro. Inhibition by the two protein configurations was virtually the same.


Assuntos
Interferons/metabolismo , Proteínas Virais/metabolismo , Animais , Cobaias , Doença pelo Vírus Ebola/tratamento farmacológico , Indutores de Interferon/farmacologia , Indutores de Interferon/uso terapêutico , Camundongos , Camundongos Endogâmicos BALB C , RNA de Cadeia Dupla/farmacologia , RNA de Cadeia Dupla/uso terapêutico , RNA Fúngico/farmacologia , RNA Fúngico/uso terapêutico , Proteínas Virais/genética , Replicação Viral/efeitos dos fármacos
2.
Antibiot Khimioter ; 57(7-8): 12-22, 2012.
Artigo em Russo | MEDLINE | ID: mdl-23350190

RESUMO

Search for drugs efficient in prophylaxis and treatment of dangerous infections (especially arboviral ones) is rather actual, since no specific therapy is available. Many-year investigations of interferon inductors showed that they had immunomodulating, antiviral and antiinflammatory effects and were low toxic. The present study demonstrated that the protective effect was the following: Venezuelan equine encephalitis (VEE)--cycloferon > amixin = ridostin, Rift Valley fever (RVF)--cycloferon > amixin > ridostin, predator pox (PP)--cycloferon > amixin = ridostin, that was obvious that cycloferon was the most active agent in the treatment of VEE, RVF and PP, thus making it possible to acknowledge its priority in prophylaxis and therapy of dangerous viral infections (DVI). Ribavirin in combination with cycloferon solution or cycloferon tablets provided shorter periods of the fever, minimized the intoxication syndrome, promoted earlier resolution of hemorrhagic eruption and lowered the frequency of complications, which was in favour of the disease prognosis.


Assuntos
Acridinas/uso terapêutico , Antivirais/uso terapêutico , Encefalomielite Equina Venezuelana/tratamento farmacológico , Febre Hemorrágica da Crimeia/tratamento farmacológico , Indutores de Interferon/uso terapêutico , Febre do Vale de Rift/tratamento farmacológico , Acridinas/farmacologia , Adolescente , Adulto , Idoso , Animais , Antivirais/farmacologia , Dengue/tratamento farmacológico , Dengue/etiologia , Encefalomielite Equina Venezuelana/etiologia , Feminino , Humanos , Indutores de Interferon/farmacologia , Ixodes/virologia , Masculino , Camundongos , Pessoa de Meia-Idade , RNA de Cadeia Dupla/farmacologia , RNA de Cadeia Dupla/uso terapêutico , RNA Fúngico/farmacologia , RNA Fúngico/uso terapêutico , Ribavirina/uso terapêutico , Febre do Vale de Rift/etiologia , Febre do Vale de Rift/transmissão , Tilorona/uso terapêutico , Adulto Jovem
3.
Vestn Otorinolaringol ; (3): 44-7, 2003.
Artigo em Russo | MEDLINE | ID: mdl-12847808

RESUMO

Children having frequent acute respiratory infections and chronic adenoiditis were given immunomodulators (ridostin, IRS-19, polyoxidonium). As a result of such prophylaxis, respiratory infections and exacerbations of chronic adenoiditis occurred in poor-health children 2-2.5 times less frequently. Their local immunity and nonspecific resistance improved. Thus, modern immunomodulators can be used in poor-health children with chronic adenoiditis to prevent acute respiratory viral infection and development of pharyngeal tonsil hypertrophy as well as to treat them.


Assuntos
Tonsila Faríngea , Adjuvantes Imunológicos/uso terapêutico , Indutores de Interferon/uso terapêutico , Tonsila Palatina/patologia , Doenças dos Seios Paranasais/prevenção & controle , RNA de Cadeia Dupla/uso terapêutico , RNA Fúngico/uso terapêutico , Criança , Pré-Escolar , Doença Crônica , Humanos , Hipertrofia/patologia , Recidiva
4.
Bull Exp Biol Med ; 134(5): 463-6, 2002 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-12802453

RESUMO

The interferon system was studied in women with genital papillomavirus infection. In most patients the interferon system was activated, while the ability of lymphocytes to respond to inductors decreased. Laserotherapy and immunomodulatory therapy with larifan, ridostin, and viferon for 1 month normalized blood interferon concentration (39.4% patients) and interferon-gamma production by lymphocytes in response to inductors (87.9% patients). After laser monotherapy these parameters returned to normal only in 13.2 and 7.6% patients, respectively. Correlation and regression analyses showed that changes in the interferon system were synchronized after immunomodulatory therapy. These data indicate that immunomodulatory therapy produces a complex effect on the interferon system. Measurements of blood interferon level can be used to predict the effect of further treatment with interferon-gamma inductors.


Assuntos
Adjuvantes Imunológicos/uso terapêutico , Doenças dos Genitais Femininos/tratamento farmacológico , Doenças dos Genitais Femininos/imunologia , Interferons/sangue , Papillomaviridae , Infecções por Papillomavirus/tratamento farmacológico , Infecções por Papillomavirus/imunologia , Infecções Tumorais por Vírus/tratamento farmacológico , Infecções Tumorais por Vírus/imunologia , Antioxidantes/uso terapêutico , Feminino , Humanos , Indutores de Interferon/uso terapêutico , Interferon Tipo I/uso terapêutico , Compostos Orgânicos , RNA de Cadeia Dupla/uso terapêutico , RNA Fúngico/uso terapêutico , Proteínas Recombinantes
5.
Vopr Virusol ; 47(6): 30-2, 2002.
Artigo em Russo | MEDLINE | ID: mdl-12508681

RESUMO

Results of experimental studies of mice and pigs infected with foot-and-mouth disease virus, minks infected with Aujeszky's disease virus, and dogs infected with canine distemper virus are described. In animals with foot-and-mouth disease and Aujeszky's disease, combined treatment with killed vaccine and immunomodulator Ridostin by the scheme of urgent prophylaxis (3 days before infection) caused 75% (foot-and-mouth disease) and 100% (Aujeszky's disease) prevention of animal death and development of generalized infection. The use of Ridostin by the scheme of urgent prophylaxis in a canine distemper infection focus arrested clinical symptoms of the disease in 50% of animals received immunomodulator. Clinical symptoms of canine distemper in the other dogs treated with immunomodulator were manifested in a mild form, and their appearance was delayed to 23-25 days after contact with infected animal.


Assuntos
Vírus da Cinomose Canina , Cinomose/prevenção & controle , Febre Aftosa/prevenção & controle , Herpesviridae , Indutores de Interferon/uso terapêutico , Picornaviridae , Pseudorraiva/prevenção & controle , Doenças dos Suínos/prevenção & controle , Vacinação , Vacinas Virais/administração & dosagem , Animais , Vírus da Cinomose Canina/imunologia , Cães , Herpesviridae/imunologia , Camundongos , Vison , Picornaviridae/imunologia , RNA de Cadeia Dupla/uso terapêutico , RNA Fúngico/uso terapêutico , Suínos , Vacinas Virais/imunologia
6.
Vopr Virusol ; 41(3): 133-5, 1996.
Artigo em Russo | MEDLINE | ID: mdl-8928508

RESUMO

Antiviral activity of rybamidil (virasol) and interferon inducers ridostine and camedone developed in Russia and introduced in practical medicine has been studied in mice with experimentally induced arboviral infections, flavivirus (tick-borne encephalitis-TBE, and yellow fever-YF) and alphavirus ones (Western and Eastern equine encephalomyelitis-WEE and EEE). Rybamidil injected subcutaneously proved to be ineffective both for prevention and treatment of these infections. Early interferon inducers ridostine and camedone (larifan) with a peak of interferon production 4 hours after injection, when used in doses of 5 and 150 mg/ kg, respectively, had a clear-cut prophylactic antiviral effect if injected 24 or 4 hours before infection. Ridostine had a distinct antiviral effect, providing up to 40% protection from TBE, YF, and WEE.


Assuntos
Acridinas/uso terapêutico , Infecções por Alphavirus/tratamento farmacológico , Infecções por Alphavirus/prevenção & controle , Infecções por Flavivirus/tratamento farmacológico , Infecções por Flavivirus/prevenção & controle , Indutores de Interferon/uso terapêutico , RNA de Cadeia Dupla/uso terapêutico , RNA Fúngico/uso terapêutico , Animais , Camundongos
7.
Antibiot Khimioter ; 40(5): 24-7, 1995 May.
Artigo em Russo | MEDLINE | ID: mdl-8534175

RESUMO

The study of the preventive and therapeutic action of some immunomodulators (ridostin, reaferon and polyribonate) used alone and in combinations was conducted on laboratory animals infected aerogenically by Marburg or Ebola virus. It was found that special preventive intranasal and intramuscular administration of ridostin provided protection of the animals infected by Marburg virus (p = 0.1) and an increase in their mean lifespan by 2.4 days (p = 0.15). In the Ebola infection combined administration of ridostin and reaferon caused an essential increase in the mean lifespan of the animals by 2.9 days (p = 0.04). None of the tested drugs had any significant positive effect when used in various combinations according to the treatment schemes in Marburg and Ebola infections in guinea pigs.


Assuntos
Adjuvantes Imunológicos/uso terapêutico , Doença pelo Vírus Ebola/tratamento farmacológico , Doença pelo Vírus Ebola/prevenção & controle , Doença do Vírus de Marburg/tratamento farmacológico , Doença do Vírus de Marburg/prevenção & controle , Aerossóis , Animais , Avaliação Pré-Clínica de Medicamentos , Quimioterapia Combinada , Cobaias , Doença pelo Vírus Ebola/mortalidade , Doença pelo Vírus Ebola/transmissão , Interferon Tipo I/uso terapêutico , Interferon alfa-2 , Interferon-alfa , Doença do Vírus de Marburg/mortalidade , Doença do Vírus de Marburg/transmissão , Compostos Orgânicos , RNA de Cadeia Dupla/uso terapêutico , RNA Fúngico/uso terapêutico , Proteínas Recombinantes , Fatores de Tempo
8.
Antibiot Khimioter ; 40(5): 28-31, 1995 May.
Artigo em Russo | MEDLINE | ID: mdl-8534176

RESUMO

The investigation of the prevention and treatment action of some immunomodulators (ridostin, reaferon and polyribonate) used alone and in combinations was conducted on laboratory animals infected aerogenically by Venezuelan equine encephalitis (VEE) virus. A lower death rate of the aerogenically infected mice (10-30 respiratory LD50) was observed after intramuscular injection of ridostin. The preventive affect of ridostin and ridostin + reaferon administered intranasally and intramuscularly was achieved in the aerogenically infected guinea pigs (10 respiratory LD50). The results of the study on the early virus reproduction in the animals were used for the choice of the treatment scheme. The immunomodulators had no effect when the treatment was started 1 day after the VEE virus infection.


Assuntos
Adjuvantes Imunológicos/uso terapêutico , Encefalomielite Equina Venezuelana/tratamento farmacológico , Encefalomielite Equina Venezuelana/prevenção & controle , Aerossóis , Animais , Avaliação Pré-Clínica de Medicamentos , Quimioterapia Combinada , Encefalomielite Equina Venezuelana/mortalidade , Encefalomielite Equina Venezuelana/transmissão , Cobaias , Interferon Tipo I/uso terapêutico , Interferon alfa-2 , Interferon-alfa , Camundongos , Compostos Orgânicos , RNA de Cadeia Dupla/uso terapêutico , RNA Fúngico/uso terapêutico , Proteínas Recombinantes , Fatores de Tempo
9.
Vopr Virusol ; 39(3): 125-8, 1994.
Artigo em Russo | MEDLINE | ID: mdl-8091753

RESUMO

Natural killer cell activity (NK) in parallel with the interferon (IFN)-alpha and IFN-gamma production as well as with a level of IFN in the blood serum were studied in 15 patients with relapsing herpes genitalis (RHG). Rhidostin, well known as an IFN-alpha inducer, was used in a dose of 2 mg once daily for 3 days subcutaneously up to a total dose of 8 mg of the preparation. The NK cell activity and IFN-alpha production were shown to decrease in RHG more significantly in the stage of remission than during the relapse of the process. As a result of rhidostin therapy the NK cell activity was restored simultaneously with the positive clinical effect of the drug. Rhidostin was found to be an efficient modifier of the IFN system functioning in patients with RHG. The above data allow a conclusion that rhidostin exhibiting an independent antiviral and immunostimulating action might be useful in patients with a remission of RHG for prevention of its relapses.


Assuntos
Antivirais/uso terapêutico , Herpes Genital/tratamento farmacológico , Herpes Genital/imunologia , Indutores de Interferon/uso terapêutico , Interferon-alfa/efeitos dos fármacos , Interferon gama/efeitos dos fármacos , Células Matadoras Naturais/efeitos dos fármacos , RNA de Cadeia Dupla/uso terapêutico , RNA Fúngico/uso terapêutico , Adulto , Testes Imunológicos de Citotoxicidade , Avaliação de Medicamentos , Feminino , Herpes Genital/sangue , Humanos , Interferon-alfa/sangue , Interferon gama/sangue , Células Matadoras Naturais/imunologia , Masculino , Recidiva , Indução de Remissão
10.
Ter Arkh ; 63(11): 19-22, 1991.
Artigo em Russo | MEDLINE | ID: mdl-1810053

RESUMO

The clinical efficacy of sodium nucleinate (SN) combined with splenin and quercetin given for lingering Flexner's dysentery in a group of 43 patients was compared with that of routine therapy used in a group of the same number of patients. It has been established that the above drug combination favours the elimination of the pathological symptoms of dyspepsia, the arrest of bacterial isolation and normalization of the immune status. Provided the effect of the combined drug treatment is insufficient, the method of choice is the administration of gene engineering alpha 2-interferon (reaferon) in combination with tocopherol acetate and rectal suppositories containing methyluracil.


Assuntos
Disenteria Bacilar/tratamento farmacológico , Shigella flexneri , Adjuvantes Imunológicos/uso terapêutico , Adulto , Doença Crônica , Avaliação de Medicamentos , Quimioterapia Combinada , Disenteria Bacilar/imunologia , Humanos , Imunidade Celular/efeitos dos fármacos , Pessoa de Meia-Idade , Ácidos Nucleicos/uso terapêutico , Quercetina/uso terapêutico , RNA Fúngico/uso terapêutico , Timopoietinas/uso terapêutico , Fatores de Tempo
13.
Patol Fiziol Eksp Ter ; (5): 24-6, 1989.
Artigo em Russo | MEDLINE | ID: mdl-2515522

RESUMO

A new non-injection method was used to study the quantitative values characterizing the condition of the microcirculatory channel of the peri-infarct zones of rat myocardium without treatment and in treatment with nitroglycerin, alpha-tocopherol, and sodium nucleinate. In combined administration of these agents the total number of capillaries per unit of tissue volume increased, with subsequent increase of the capillary diameter, the exchange surface and the capacity of the capillary channel. These changes in the micro-circulatory channel were reflected in reduction of the focus of myocardial infarction. The authors discuss the mechanisms of the limiting effect of the complex of agents on restriction of the focus of affection in the early and late terms of myocardial infarction development.


Assuntos
Infarto do Miocárdio/tratamento farmacológico , Miocárdio/patologia , Nitroglicerina/uso terapêutico , Ácidos Nucleicos/uso terapêutico , RNA Fúngico/uso terapêutico , Vitamina E/uso terapêutico , Animais , Avaliação Pré-Clínica de Medicamentos , Quimioterapia Combinada , Feminino , Coração/efeitos dos fármacos , Masculino , Microcirculação/efeitos dos fármacos , Microcirculação/fisiopatologia , Infarto do Miocárdio/fisiopatologia , Necrose/patologia , Ratos , Fatores de Tempo
15.
Vopr Virusol ; 34(2): 186-92, 1989.
Artigo em Russo | MEDLINE | ID: mdl-2527446

RESUMO

A comparative analysis of the effectiveness of national phosphonic acid derivatives (FUK and FMK) and acyclic nucleoside, acycloguanosine (Acg), as well as interferon (INF) inducers, lafarin and ridostin, was carried out on the model of herpetic conjunctivitis in rabbits and guinea pigs. Upon therapeutic-prophylactic administration, lafarin reduced the intensity of eye symptoms 2-fold as compared with the controls (infected but untreated guinea-pigs). In rabbits with herpetic conjunctivitis, the therapeutic schedule of the use of FMK (FUK) and Acg shortened the duration of the disease by 7 and 11 days, respectively, as compared with the control. The combined use of chemical drugs and INF inducers, lafarin or ridostin, reduced the intensity of the disease manifestations 3-fold and shortened the duration of the disease by 8-11 days. The survival rate was 80%-100%. Use of the combination of the two chemical drugs gave an additive effect. The synergistic effect was observed with FMK used in combination with lafarin.


Assuntos
Indutores de Interferon/uso terapêutico , Ceratite Dendrítica/tratamento farmacológico , Compostos Organofosforados/uso terapêutico , Ácido Fosfonoacéticos/uso terapêutico , Animais , Cefalexina/uso terapêutico , Modelos Animais de Doenças , Avaliação Pré-Clínica de Medicamentos , Quimioterapia Combinada , Feminino , Foscarnet , Cobaias , Masculino , Ácido Fosfonoacéticos/análogos & derivados , RNA de Cadeia Dupla/uso terapêutico , RNA Fúngico/uso terapêutico , Coelhos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...